Fernanda Pavani Stamm Maldaner

Produção Bibliográfica

    2018 (Total: 1)
  • ISSN Analysis of Recombinant Human Parathyroid Hormone by In Vitro Bioassay and Chromatographic Methods (Latin American Journal of Pharmacy)
    2017 (Total: 3)
  • doi ISSN Analysis of streptokinase by validated liquid chromatography methods and correlation with an in vitro bioassay (Journal of Separation Science (Print))
  • doi ISSN Assessment of rhIL-11 by a Validated SE-LC Method and its Correlation with RP-LC and CZE Methods (Current Pharmaceutical Analysis)
  • doi ISSN Evaluation of recombinant human parathyroid hormone by CZE method and its correlation with in vitro bioassay and LC methods (Talanta (Oxford))
    2016 (Total: 1)
  • ISSN Validation of an Alternative Cell Culture Bioassay for the Potency Assessment of Recombinant Human Erythropoietin (ATLA. Alternatives to Laboratory Animals)
    2015 (Total: 2)
  • doi ISSN Evaluation of Botulinum Toxin Type A by Bioassays and a Validated Reversed-Phase Liquid Chromatography Method (Analytical Methods (Print))
  • ISSN Validation of the Chromogenic Bioassay for the Potency Assessment of Streptokinase in Biopharmaceutical Formulations (Journal of Analytical & Bioanalytical Techniques)
    2014 (Total: 3)
  • doi ISSN Stability-indicating capillary zone electrophoresis method for the assessment of recombinant human interleukin-11 and its correlation with reversed-phase liquid chromatography and biossay (Talanta (Oxford))
  • doi ISSN Validation of a stability-indicating micellar electrokinetic capillary method for the assessment of febuxostat and its correlation with the reversed-phase LC method (Analytical Methods (Print))
  • ISSN Validation of Stability-indicating RP-LC Method for the Determination of Febuxostat in Pharmaceutical Formulations (Latin American Journal of Pharmacy)
    2013 (Total: 3)
  • doi ISSN Assessment of Human Parathyroid Hormone: Correlation of LC Methods with Bioassays (Analyst (London. 1877. Print))
  • doi ISSN Assessment of recombinant human erythropoietin by alternative bioassay and its correlation with liquid chromatography methods (Analytical Methods (Print))
  • doi ISSN Development and Validation of a Stability-Indicating Size-Indicating Size-Exclusion LC Method for the Determination of rhIFN-α2a in Pharmaceutical Formulations (Journal of AOAC International)
    2012 (Total: 1)
  • doi ISSN Validation of a Stability-indicating RP-LC Method for the Assessment of Recombinant Human Interleukin-11 and Its Correlation with Bioassay (Analytical Sciences)
    2010 (Total: 1)
  • doi ISSN Development and validation of a dissolution test with reversed-phase liquid chromatography analysis for rupatadine in tablet dosage forms (Química Nova (Impresso))
    2017 (Total: 1)
  • ISSN Assessment of rhIL-11 by a Validated SE-LC Method and its Correlation with RP-LC and CZE Methods (Current Pharmaceutical Analysis)
    2016 (Total: 1)
  • Analysis of streptokinase by validated LC methods and correlation with in vitro bioassay
    2016 (Total: 2)
  • Evaluation of an in vitro cell culture bioassay for the potency assessment of recombinant human erythropoietin (48th Brazilian Congress of Pharmacology and Experimental Therapeutics and 21th Latin American Congress of Pharmacology (LATINFARMA))
  • Evaluation of Insulin Glargine by Size Exclusion Liquid Chromatography Method (III Congress of the Brazilian Association of Pharmaceutical Sciences)
    2015 (Total: 4)
  • Assessment of Recombinant Human Parathyroid Hormone in Biopharmaceutical Formulations. (XVIII Congresso da Federación Farmacéutica Sudamericana e 8º Congresso RIOPHARMA de Ciências Farmacêuticas.)
  • Development of a Capillary Zone Electrophoresis Method for the Assessment of Recombinant Human Parathyroid Hormone. (10th International Congress of Pharmaceutical Sciences (CIFARP))
  • Evaluation of Botulinum Toxin Type A by Reversed-Phase Liquid Chromatography Method. (XVIII Congresso da Federación Farmacéutica Sudamericana e 8º Congresso RIOPHARMA de Ciências Farmacêuticas.)
  • Validation of a RP-LC Method for the Analysis of Insulin Glargine. (10th International Congress of Pharmaceutical Sciences (CIFARP))
    2014 (Total: 3)
  • Cytotoxicity and Biological Reactivity Evaluation of Pharmaceuticals (1 Latin American Congress of Clinical and Laboratorial Toxicology)
  • Development and validation of a stability-indicating LC method for the analysis of Rivaroxaban (Simpósio Brasileiro de Cromatografia e Técnicas Afins)
  • Reversed-phase liquid chromatography method for the analysis of Botulinum Toxin. (Simpósio Brasileiro de Cromatografia e Técnicas Afins)
    2013 (Total: 1)
  • Recombinant human parathyroid hormone: biological and physicochemical characterization of biopharmaceutical formulations. (IX International Congress of Pharmaceutical Sciences - CIFARP)
    2012 (Total: 3)
  • DEVELOPMENT OF A STABILITY-INDICATING RP-LC METHOD FOR THE ANALYSIS OF FEBUXOSTAT (Congresso Latino-americano de Cromatografia e Técnicas Relacionadas (COLACRO XIV))
  • EVALUATION OF RECOMBINANT HUMAN INTERLEUKIN-11 IN BIOPHARMACEUTICAL FORMULATIONS. (XVI CONGRESSO CATARINENSE DE FARMACÊUTICOS E BIOQUÍMICOS.)
  • VALIDATION OF A RP-LC METHOD FOR THE ANALYSIS OF A RECOMBINANT HUMAN PARATHYROID HORMONE. (CONGRESSO LATINO-AMERICANO DE CROMATOGRAFIA E TÉCNICAS RELACIONADAS (COLACRO XIV).)
    2011 (Total: 4)
  • ANTI-FACTOR IIa ASSAY FOR THE POTENCY ASSESSMENT OF UNFRACTIONATED HEPARINS (XXVI Reunião Anual da Federação de Sociedades de Biologia Experimental - FeSBE)
  • ASSESSMENT OF SOMATROPIN IN PHARMACEUTICAL FORMULATIONS BY LIQUID CHROMATOGRAPHY AND CAPILLARY ELECTROPHORESIS METHODS. (8 International Congress of Pharmaceutical Sciences.)
  • DEVELOPMENT AND VALIDATION OF REVERSED-PHASE LIQUID CHROMATOGRAPHY METHOD FOR THE EVALUATION OF RECOMBINANT HUMAN INTERLEUKIN-11. CORRELATION WITH THE BIOASSAY (II International Symposium of Pharmaceutical Sciences.)
  • RECOMBINANT HUMAN INTERLEUKIN-11: BIOLOGICAL AND PHYSICOCHEMICAL CHARACTERIZATION OF BIOPHARMACEUTICAL FORMULATIONS. (2 INTERNATIONAL CONGRESS ON IMMUNOPHARMACOLOGY)
    2009 (Total: 5)
  • ANÁLISE DO FATOR ESTIMULADOR DA COLÔNIA DE GRANULÓCITOS-MACRÓFAGOS HUMANO RECOMBINANTE EM FORMULAÇOES FARMACÊUTICAS. (24ª Jornada Acadêmica Integrada, UFSM)
  • AVALIAÇÃO DA UNIFORMIDADE DE CONTEÚDO DE FORMULAÇÃO FARMACÊUTICA DE ENOXAPARINA SÓDICA (24ª Jornada Acadêmica Integrada, UFSM)
  • CARACTERIZAÇÃO DE ERITROPOIETINA HUMANA RECOMBINANTE E SUAS FORMAS MODIFICADAS (24ª Jornada Acadêmica Integrada, UFSM)
  • DEVELOPMENT AND VALIDATION OF DISSOLUTION TEST FOR RUPATADINE IN SOLID DOSAGE FORMS (7th International Congress of Pharmaceutical Sciences - CIFARP)
  • EVOLUATION OF FELYPRESSIN BY LIQUID CHROMATOGRAPHY METHOD AND BIOASSAY (XXIV Reunião Anual da Federação de Sociedades de Biologia Experimental - FeSBE)
    2008 (Total: 1)
  • PARÂMETROS TOXICOLÓGICOS EM CARPAS ( CYPRINUS CARPIO) EXPOSTOS A UMA FORMULAÇÃO COMERCIAL DO INSETICIDA FIPRONIL EM LABORATÓRIO (23ª Jornada Acadêmica Integrada, UFSM)
    2015 (Total: 1)
  • Estudo de método por cromatografia líquida em fase reversa para avaliação de toxina botulínica tipo A. (XXX Jornada Acadêmica Integrada ? JAI)
    2013 (Total: 3)
  • AVALIAÇÃO DE FILGRASTIMA EM FORMULAÇÃO BIOFARMACÊUTICA POR MÉTODOS CROMATOGRÁFICOS (XXVIII JORNADA ACADÊMICA INTEGRADA DA UNIVERSIDADE FEDERAL DE SANTA MARIA)
  • DESENVOLVIMENTO DE MÉTODO POR CROMATOGRAFIA LÍQUIDA POR EXCLUSÃO MOLECULAR PARA AVALIAÇÃO DE HORMÔNIO DA PARATIREÓIDE HUMANO RECOMBINANTE EM FORMULAÇÃO BIOFARMACÊUTICA (XXVIII JORNADA ACADÊMICA INTEGRADA DA UNIVERSIDADE FEDERAL DE SANTA MARIA)
  • ERITROPOEITINA HUMANA RECOMBINANTE: ESTUDOS DE CORRELAÇAO ENTRE ENSAIOS BIOLÓGICOS E MÉTODOS CROMATOGRÁFICOS (XXVIII JORNADA ACADÊMICA INTEGRADA, DA UNIVERSIDADE FEDERAL DE SANTA MARIA)
    2011 (Total: 2)
  • ANÁLISE DE SOMATROPINA EM FORMULAÇÕES FARMACÊUTICAS POR CROMATOGRAFIA LÍQUIDA E ELETROFORESE CAPILAR (XXVI JORNADA ACADÊMICA INTEGRADA DA UNIVERSIDADE FEDERAL DE SANTA MARIA)
  • AVALIAÇÃO DO HORMÔNIO DA PARATIREÓIDE HUMANO RECOMBINANTE EM FORMULAÇÃO FARMACÊUTICA. (XXVI JORNADA ACADÊMICA INTEGRADA DA UNIVERSIDADE FEDERAL DE SANTA MARIA)

Produção Técnica

    2016 (Total: 1)
  • Avaliação do Hormônio da Paratireóide Humano Recombinante por métodos físico-químicos e bioensaio in vitro
    2015 (Total: 1)
  • Assessment of Recombinant Human Parathyroid Hormone in Biopharmaceutical Formulations.
    2013 (Total: 1)
  • Recombinant Human Parathyroid Hormone: Biological and Physicochemical characterization of Biopharmaceutical Formulations
    2012 (Total: 1)
  • Validation of a RP-LC Method for the Analysis of Recombinant Human Parathyroid Hormone
    2010 (Total: 1)
  • CARACTERIZAÇÃO E AVALIAÇÃO DE ATIVIDADE BIOLÓGICA DE HEPARINAS NÃO FRACIONADAS
    2011 (Total: 1)
  • STUDY OF RP-LC METHOD FOR THE ANALYSIS OF RECOMBINANT PARATHYROID HORMONE IN BIOPHARMACEUTICAL FORMULATIONS

Produção Artística

Não informado

Orientações Concluídas

Não informado